Skip to main content
Top
Published in: Current Atherosclerosis Reports 2/2014

01-02-2014 | Coronary Heart Disease (JA Farmer, Section Editor)

Arterial Stiffness as a Risk Factor for Coronary Artery Disease

Authors: Josh Liao, John Farmer

Published in: Current Atherosclerosis Reports | Issue 2/2014

Login to get access

Abstract

Hypertension is a major modifiable risk factor, and clinical trials have demonstrated that successful reduction of elevated blood pressure to target levels translates into decreased risk for the development of coronary artery disease, stroke, heart failure, and renal failure. The arterial system had previously been regarded as a passive conduit for the transportation of arterial blood to peripheral tissues. The physiologic role the arterial system was greatly expanded by the recognition of the central role of the endothelial function in a variety of physiologic processes. The role of arterial function and structure in cardiovascular physiology was expanded with the development of a variety of parameters that evaluate arterial stiffness. Markers of arterial stiffness have been correlated with cardiovascular outcomes, and have been classified as an emerging risk factor that provides prognostic information beyond standard stratification strategies involving hypertension, diabetes, obesity, dyslipidemia and smoking. Multiple epidemiologic studies have correlated markers of arterial stiffness such as pulse-wave velocity, augmentation index and pulse pressure with risk for the development of fatal and nonfatal cardiovascular events. Additionally, measurements of arterial stiffness had clarified the results of clinical trials that demonstrated differing impacts on clinical outcomes, despite similar reductions in blood pressure, as measured by brachial and sphygmomanometry.
Literature
1.••
go back to reference Hopkins PN. Molecular biology of atherosclerosis. Physiol Rev. 2013;93(3):1317–542. Excellent overview of the basic science pathways involved in the initiation and progression of atherosclerosis. The paper discusses the molecular basis of the pathologic changes in the vascular system that result in the long-term development of loss of arterial compliance.PubMedCrossRef Hopkins PN. Molecular biology of atherosclerosis. Physiol Rev. 2013;93(3):1317–542. Excellent overview of the basic science pathways involved in the initiation and progression of atherosclerosis. The paper discusses the molecular basis of the pathologic changes in the vascular system that result in the long-term development of loss of arterial compliance.PubMedCrossRef
2.
go back to reference Safar ME. Arterial aging–hemodynamic changes and therapeutic options. Nat Rev Cardiol. 2010;7(8):442–9.PubMedCrossRef Safar ME. Arterial aging–hemodynamic changes and therapeutic options. Nat Rev Cardiol. 2010;7(8):442–9.PubMedCrossRef
3.
go back to reference Langille BL. Remodeling of developing and mature arteries: endothelium, smooth muscle, and matrix. J Cardiovasc Pharmacol. 1993;21 Suppl 1:S11–7.PubMedCrossRef Langille BL. Remodeling of developing and mature arteries: endothelium, smooth muscle, and matrix. J Cardiovasc Pharmacol. 1993;21 Suppl 1:S11–7.PubMedCrossRef
4.
go back to reference • Gauthier-Bastien, A., et al. Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease. Clin Exp Hypertens, 2013. Overview of the maladaptive remodeling process that delineates the pathologic processes in the histologic changes within the vasculature resulting in arterial stiffness. • Gauthier-Bastien, A., et al. Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease. Clin Exp Hypertens, 2013. Overview of the maladaptive remodeling process that delineates the pathologic processes in the histologic changes within the vasculature resulting in arterial stiffness.
5.
go back to reference London GM, Cohn JN. Prognostic application of arterial stiffness: task forces. Am J Hypertens. 2002;15(8):754–8.PubMedCrossRef London GM, Cohn JN. Prognostic application of arterial stiffness: task forces. Am J Hypertens. 2002;15(8):754–8.PubMedCrossRef
6.
go back to reference de Souza F, Muxfeldt ES, Salles GF. Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management. Expert Rev Cardiovasc Ther. 2012;10(6):735–45.PubMedCrossRef de Souza F, Muxfeldt ES, Salles GF. Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management. Expert Rev Cardiovasc Ther. 2012;10(6):735–45.PubMedCrossRef
7.
go back to reference Raij L, Gonzalez-Ochoa AM. Vascular compliance in blood pressure. Curr Opin Nephrol Hypertens. 2011;20(5):457–64.PubMedCrossRef Raij L, Gonzalez-Ochoa AM. Vascular compliance in blood pressure. Curr Opin Nephrol Hypertens. 2011;20(5):457–64.PubMedCrossRef
8.
go back to reference Nichols WW. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens. 2005;18(1 Pt 2):3S–10S.PubMedCrossRef Nichols WW. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens. 2005;18(1 Pt 2):3S–10S.PubMedCrossRef
9.
go back to reference O'Rourke MF, Kelly RP. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens. 1993;11(4):327–37.PubMedCrossRef O'Rourke MF, Kelly RP. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens. 1993;11(4):327–37.PubMedCrossRef
10.
go back to reference O'Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005;45(4):652–8.PubMedCrossRef O'Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005;45(4):652–8.PubMedCrossRef
11.
go back to reference Yildiz O. Vascular smooth muscle and endothelial functions in aging. Ann N Y Acad Sci. 2007;1100:353–60.PubMedCrossRef Yildiz O. Vascular smooth muscle and endothelial functions in aging. Ann N Y Acad Sci. 2007;1100:353–60.PubMedCrossRef
12.
go back to reference Franklin SS et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96(1):308–15.PubMedCrossRef Franklin SS et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96(1):308–15.PubMedCrossRef
13.•
go back to reference Chirinos JA. Arterial stiffness: basic concepts and measurement techniques. J Cardiovasc Transl Res. 2012;5(3):243–55. Basic science overview of the principles involved in the measurement of arterial stiffness modification.PubMedCrossRef Chirinos JA. Arterial stiffness: basic concepts and measurement techniques. J Cardiovasc Transl Res. 2012;5(3):243–55. Basic science overview of the principles involved in the measurement of arterial stiffness modification.PubMedCrossRef
14.
go back to reference Mendis S. The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective. Prog Cardiovasc Dis. 2010;53(1):10–4.PubMedCrossRef Mendis S. The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective. Prog Cardiovasc Dis. 2010;53(1):10–4.PubMedCrossRef
15.
go back to reference Franklin SS. Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease. J Hypertens Suppl. 1999;17(5):S29–36.PubMed Franklin SS. Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease. J Hypertens Suppl. 1999;17(5):S29–36.PubMed
16.
go back to reference Agabiti-Rosei E et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007;50(1):154–60.PubMedCrossRef Agabiti-Rosei E et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007;50(1):154–60.PubMedCrossRef
17.
go back to reference Wilkinson IB et al. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525(Pt 1):263–70.PubMedCrossRef Wilkinson IB et al. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525(Pt 1):263–70.PubMedCrossRef
18.
go back to reference Safar ME et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39(3):735–8.PubMedCrossRef Safar ME et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39(3):735–8.PubMedCrossRef
19.
go back to reference Blacher J et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33(5):1111–7.PubMedCrossRef Blacher J et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33(5):1111–7.PubMedCrossRef
20.
go back to reference Meaume S et al. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol. 2001;21(12):2046–50.PubMedCrossRef Meaume S et al. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol. 2001;21(12):2046–50.PubMedCrossRef
21.
go back to reference Taquet A et al. Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol. 1993;9(3):298–306.PubMedCrossRef Taquet A et al. Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol. 1993;9(3):298–306.PubMedCrossRef
22.
go back to reference Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54(6):1328–36.PubMedCrossRef Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54(6):1328–36.PubMedCrossRef
23.
go back to reference Boutouyrie P et al. Cardiovascular risk assessment through target organ damage: role of carotid to femoral pulse wave velocity. Clin Exp Pharmacol Physiol. 2008;35(4):530–3.PubMedCrossRef Boutouyrie P et al. Cardiovascular risk assessment through target organ damage: role of carotid to femoral pulse wave velocity. Clin Exp Pharmacol Physiol. 2008;35(4):530–3.PubMedCrossRef
24.
go back to reference Zoungas S, Asmar RP. Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol. 2007;34(7):647–51.PubMedCrossRef Zoungas S, Asmar RP. Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol. 2007;34(7):647–51.PubMedCrossRef
25.
go back to reference Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–27.PubMedCrossRef Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–27.PubMedCrossRef
26.
go back to reference Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38(4):932–7.PubMedCrossRef Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38(4):932–7.PubMedCrossRef
27.
go back to reference Chen CH et al. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension. 1996;27(2):168–75.PubMedCrossRef Chen CH et al. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension. 1996;27(2):168–75.PubMedCrossRef
28.
go back to reference Gatzka CD et al. Correction of carotid augmentation index for heart rate in elderly essential hypertensives. ANBP2 Investigators. Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor- and Diuretic-Based Treatment of Hypertension in the Elderly. Am J Hypertens. 2001;14(6 Pt 1):573–7.PubMedCrossRef Gatzka CD et al. Correction of carotid augmentation index for heart rate in elderly essential hypertensives. ANBP2 Investigators. Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor- and Diuretic-Based Treatment of Hypertension in the Elderly. Am J Hypertens. 2001;14(6 Pt 1):573–7.PubMedCrossRef
29.
go back to reference Nichols WW, Singh BM. Augmentation index as a measure of peripheral vascular disease state. Curr Opin Cardiol. 2002;17(5):543–51.PubMedCrossRef Nichols WW, Singh BM. Augmentation index as a measure of peripheral vascular disease state. Curr Opin Cardiol. 2002;17(5):543–51.PubMedCrossRef
30.
go back to reference Agnoletti D et al. Central hemodynamic modifications in diabetes mellitus. Atherosclerosis. 2013;230(2):315–21.PubMedCrossRef Agnoletti D et al. Central hemodynamic modifications in diabetes mellitus. Atherosclerosis. 2013;230(2):315–21.PubMedCrossRef
31.
go back to reference Domanski MJ et al. Isolated systolic hypertension : prognostic information provided by pulse pressure. Hypertension. 1999;34(3):375–80.PubMedCrossRef Domanski MJ et al. Isolated systolic hypertension : prognostic information provided by pulse pressure. Hypertension. 1999;34(3):375–80.PubMedCrossRef
32.
go back to reference Franklin SS et al. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999;100(4):354–60.PubMedCrossRef Franklin SS et al. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999;100(4):354–60.PubMedCrossRef
34.
go back to reference Aatola H et al. Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study. Hypertension. 2010;55(3):806–11.PubMedCrossRef Aatola H et al. Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study. Hypertension. 2010;55(3):806–11.PubMedCrossRef
35.••
go back to reference Kaess BM et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308(9):875–81. Excellent paper providing clinical evidence that measurements of arterial stiffness and endothelial function serve as a harbinger of essential hypertension in individuals who are initially normotensive.PubMedCentralPubMedCrossRef Kaess BM et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308(9):875–81. Excellent paper providing clinical evidence that measurements of arterial stiffness and endothelial function serve as a harbinger of essential hypertension in individuals who are initially normotensive.PubMedCentralPubMedCrossRef
36.
go back to reference Dudenbostel T, Glasser SP. Effects of antihypertensive drugs on arterial stiffness. Cardiol Rev. 2012;20(5):259–63.PubMedCrossRef Dudenbostel T, Glasser SP. Effects of antihypertensive drugs on arterial stiffness. Cardiol Rev. 2012;20(5):259–63.PubMedCrossRef
37.
go back to reference Poulter NR et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet. 2005;366(9489):907–13.PubMedCrossRef Poulter NR et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet. 2005;366(9489):907–13.PubMedCrossRef
38.
go back to reference Williams B, Lacy PS. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate. J Am Coll Cardiol. 2009;54(8):705–13.PubMedCrossRef Williams B, Lacy PS. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate. J Am Coll Cardiol. 2009;54(8):705–13.PubMedCrossRef
Metadata
Title
Arterial Stiffness as a Risk Factor for Coronary Artery Disease
Authors
Josh Liao
John Farmer
Publication date
01-02-2014
Publisher
Springer US
Published in
Current Atherosclerosis Reports / Issue 2/2014
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-013-0387-8

Other articles of this Issue 2/2014

Current Atherosclerosis Reports 2/2014 Go to the issue

Nonstatin Drugs (WB Borden, Section Editor)

Treatment of Cholesterol in the Elderly: Statins and Beyond

Statin Drugs (MB Clearfield, Section Editor)

How Low an LDL-C Should We Go With Statin Therapy?

Nonstatin Drugs (WB Borden, Section Editor)

Cardiometabolic Impact of Non-Statin Lipid Lowering Therapies

Coronary Heart Disease (JA Farmer, Section Editor)

Applications of miRNA Technology for Atherosclerosis

Nonstatin Drugs (WB Borden, Section Editor)

Omega-3 Fatty Acids: A Growing Ocean of Choices

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine